2016年6月24-25日,临床肿瘤学新进展学术研讨会——Best of ASCO Event in China 2016在杭州召开。25日上午的
三项研究摘要编号和题目:
Abstract 8504
CONVERT: An international randomised controlled trial of concurrent chemo-radiotherapy (cCTRT) comparing twice-daily (BD) and once-daily (OD) radiotherapy (RT) schedules in patients with limited stage small cell lung cancer (LS-
Abstract 108
Efficacy and safety of crizotinib in patients (pts) with advanced MET exon 14-altered non-small cell lung cancer (
Abstract 100
CheckMate 032: Nivolumab (N) alone or in combination with ipilimumab (I) for the treatment of recurrent small cell lung cancer (SCLC).
直通车:范云教授分享三项肺癌重要研究
会议专题》》》2016临床肿瘤学新进展学术研讨会(BOA)